Suscribirse

Masking for COVID-19 Is Associated with Decreased Emergency Department Utilization for Non-COVID Viral Illnesses and Respiratory Conditions in Maryland - 28/09/21

Doi : 10.1016/j.amjmed.2021.06.008 
Zachary D.W. Dezman, MD, MS, MS a, b, , Benoit Stryckman, MA a, Kori S. Zachrison, MD, MSc c, Ryan M. Conrad, PhD d, David Marcozzi, MD, MHS-CL a, Laura Pimentel, MD a, Margaret Samuels-Kalow, MD, MPhil, MSHP c, Charles B. Cairns, MD e
a Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, Md 
b Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Md 
c Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 
d US Food and Drug Administration, Rockville, Md 
e Drexel University, Philadelphia, Penn 

Requests for reprints should be addressed to Zachary Dezman, MD, MS, MS, Department of Emergency Medicine, University of Maryland School of Medicine, 110 S Paca Street, 6th Floor, Suite 200, Baltimore, MD, 21201.Department of Emergency MedicineUniversity of Maryland School of Medicine110 S Paca Street, 6th Floor, Suite 200BaltimoreMD21201

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Masking, which is known to decrease the transmission of respiratory viruses, was not widely practiced in the United States until the coronavirus disease 2019 (COVID-19) pandemic. This provides a natural experiment to determine whether the percentage of community masking was associated with decreases in emergency department (ED) visits due to non-COVID viral illnesses (NCVIs) and related respiratory conditions.

Methods

In this observational study of ED encounters in a 11-hospital system in Maryland during 2019-2020, year-on-year ratios for all complaints were calculated to account for “lockdowns” and the global drop in ED visits due to the pandemic. Encounters for specific complaints were identified using the International Classification of Diseases, version 10. Encounters with a positive COVID test were excluded. Linear regression was used to determine the association of publicly available masking data with ED visits for NCVI and exacerbations of asthma and chronic obstructive pulmonary disease (COPD), after adjusting for patient age, sex, and medical history.

Results

There were 285,967 and 252,598 ED visits across the hospital system in 2019 and 2020, respectively. There was a trend toward an association between the year-on-year ratio for all ED visits and the Maryland stay-at-home order (parameter estimate = -0.0804, P = .10). A 10% percent increase in the prevalence of community masking was associated with a 17.0%, 8.8%, and 9.4% decrease in ED visits for NCVI and exacerbations of asthma exacerbations and chronic obstructive pulmonary disease, respectively (P < .001 for all).

Conclusions

Increasing the prevalence of masking is associated with a decrease in ED visits for viral illnesses and exacerbations of asthma and COPD. These findings may be valuable for future public health responses, particularly in future pandemics with respiratory transmission or in severe influenza seasons.

El texto completo de este artículo está disponible en PDF.

Keywords : COVID, Emergency medicine, Epidemiology, Public health


Esquema


 Funding: ZDWD, KSZ, the data extraction, and data analysis, were all supported through grants from National Foundation of Emergency Medicine. The National Foundation of Emergency Medicine was not involved in the development of the analysis or the contents of the report.
 Conflicts of Interest: ZDWD reports serving on an advisory board for Perdue Pharmaceuticals to assist with the development medications to be used against the opioid epidemic. CBC reports serving as a consultant to bioMerieux on biomarkers; as the President of the Board of Directors of the National Foundation of Emergency Medicine (NFEM), a non-profit organization dedicated to the development of emergency medicine research, innovation and investigators; and receives funding for COVID-19 research from the National Institutes of Health (NIAID, NHLBI) and the Bill & Melinda Gates Foundation. BS, RMC, DM, LP, MS-K report none.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 134 - N° 10

P. 1247-1251 - octobre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Acute Hypoxia in a 78-Year-Old Female with Bacteremia and a History of Syphilis
  • Matthew J. Lacey, Keith B. Armitage, Ankur Kalra
| Artículo siguiente Artículo siguiente
  • Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections
  • Jennifer Y. So, Nathan N. O'Hara, Blaine Kenaa, John G. Williams, Christopher L. deBorja, Julia F. Slejko, Zafar Zafari, Michael Sokolow, Paul Zimand, Meagan Deming, Jason Marx, Andrew N. Pollak, Robert M. Reed

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.